AMADEO, ELISABETH
 Distribuzione geografica
Continente #
NA - Nord America 1.158
AS - Asia 513
EU - Europa 489
SA - Sud America 74
Continente sconosciuto - Info sul continente non disponibili 45
AF - Africa 8
OC - Oceania 1
Totale 2.288
Nazione #
US - Stati Uniti d'America 1.122
RU - Federazione Russa 294
SG - Singapore 211
CN - Cina 122
IT - Italia 88
BD - Bangladesh 64
BR - Brasile 64
VN - Vietnam 38
HK - Hong Kong 33
FR - Francia 23
DE - Germania 22
GB - Regno Unito 22
CA - Canada 19
IN - India 16
JP - Giappone 9
PL - Polonia 6
FI - Finlandia 5
MX - Messico 5
NL - Olanda 5
ES - Italia 4
LT - Lituania 4
SE - Svezia 4
AT - Austria 3
ID - Indonesia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
HN - Honduras 2
IQ - Iraq 2
JM - Giamaica 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PK - Pakistan 2
SV - El Salvador 2
TR - Turchia 2
ZA - Sudafrica 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.243
Città #
Dallas 736
Singapore 148
Ashburn 59
Moscow 56
San Jose 34
Hong Kong 33
Beijing 31
New York 29
Los Angeles 20
Santa Clara 18
Ho Chi Minh City 16
Milan 15
Lauterbourg 13
Munich 12
Phoenix 12
Council Bluffs 10
Orem 10
Hanoi 9
São Paulo 9
Tokyo 9
Hefei 8
London 8
Montreal 8
Poplar 7
Chicago 6
Cesano Boscone 5
Chennai 5
North Bergen 5
Rome 5
Secaucus 5
Shanghai 5
Warsaw 5
Brooklyn 4
Denver 4
Guangzhou 4
Manchester 4
Newark 4
Stockholm 4
Toronto 4
Boardman 3
Buffalo 3
Cleveland 3
Frankfurt am Main 3
Houston 3
Mumbai 3
Naples 3
Tianjin 3
Washington 3
West Palm Beach 3
Amsterdam 2
Atlanta 2
Bari 2
Belo Horizonte 2
Biên Hòa 2
Boston 2
Brescia 2
Brussels 2
Charlotte 2
Chengdu 2
Dhaka 2
Duque de Caxias 2
Fortaleza 2
Helena 2
Helsinki 2
Ipoh 2
Islington 2
Jinhua 2
Johannesburg 2
Lappeenranta 2
Managua 2
Mexico City 2
Miano 2
Milwaukee 2
Monza 2
Nuremberg 2
Oklahoma City 2
Orlando 2
Pelotas 2
Phủ Lý 2
Piazzolla 2
Querétaro 2
Rio de Janeiro 2
San Marco Evangelista 2
San Salvador 2
Santa Fe 2
São José dos Campos 2
Adel 1
Agadir 1
Alajuela 1
Alexandria 1
Alto Paraguai 1
Amstelveen 1
Anchorage 1
Ann Arbor 1
Annapolis 1
Antakya 1
Avaré 1
Avellino 1
Balneário Gaivota 1
Bangkok 1
Totale 1.497
Nome #
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab 445
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study 428
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma 162
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study 156
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 141
Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents 125
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 120
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 117
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 115
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma 106
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab 100
Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes 99
Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications 88
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients 86
Totale 2.288
Categoria #
all - tutte 5.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 1 6 5
2024/2025104 6 0 0 3 8 10 11 16 5 5 4 36
2025/20261.972 98 374 461 158 125 51 61 109 270 57 110 98
2026/2027200 47 47 49 57 0 0 0 0 0 0 0 0
Totale 2.288